[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342090-105":59,"doc-detail-342090-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-of-pd-l1-pd-l2-and-inflammatory-gene-expression-profile-in-locally-advanced-head-and-neck-squamous-cell-carcinoma","Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma","","Retrospective analysis characterizes programmed death-ligand 1 (PD-L1), programmed death-ligand 2 (PD-L2), and the T-cell–inflamed gene expression profile (TcellinfGEP) and evaluates their links to clinical outcomes in locoregionally advanced head and neck squamous cell carcinoma. In 366 South Korean patients treated from 2000–2015, PD-L1 positivity occurred in 83.6% and PD-L2 in 85.4%, while high TcellinfGEP was seen in 73.2%. Correlations between PD-L1 and PD-L2 were moderate, and only high TcellinfGEP independently predicted longer overall and recurrence-free survival in multivariable models.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-of-pd-l1-pd-l2-and-inflammatory-gene-expression-profile-in-locally-advanced-head-and-neck-squamous-cell-carcinoma/342090/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-of-pd-l1-pd-l2-and-inflammatory-gene-expression-profile-in-locally-advanced-head-and-neck-squamous-cell-carcinoma/342090.png","ImageObject",300,407,{"name":92,"@type":93},"Quinn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What biomarkers were evaluated in this study of locoregionally advanced head and neck squamous cell carcinoma?","Question",{"text":112,"@type":113},"The study assessed PD-L1 and PD-L2 expression on tumor and immune-infiltrating cells, and the T-cell–inflamed gene expression profile (TcellinfGEP).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers measure PD-L1 and PD-L2 positivity?",{"text":117,"@type":113},"Positivity was defined using combined positive score or immunohistochemistry proportion score greater than 1, based on tumor and immune-infiltrating cells.",{"name":119,"@type":110,"acceptedAnswer":120},"Which biomarker was independently associated with survival outcomes?",{"text":121,"@type":113},"High TcellinfGEP, but not PD-L1 or PD-L2 expression, was independently associated with longer overall survival and recurrence-free survival in multivariable analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},342090,1790538250,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","ORIGINAL ARTICLE  \nExpression of PD-L1, PD-L2, and inﬂammatory gene expression proﬁle in locally advanced head and neck squamous cell carcinoma  \nM. H. Hong1y, S. Park2y, T. Vo3, J. Cho4, H. A. Jung2, S.-H. Lee2, S.-H. Kim5, H. Zhou3, D. Chirovsky3, Y. W. Koh5, S. O. Yoon6, A. L. Webber3, B. Gumuscu3, B. C. Cho1 􀀂 & M.-J. Ahn2 􀀂  \n1Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, Seoul; 2Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; 3Merck & Co., Inc., Rahway, USA; 4Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Departments of 5Otorhinolaryngology; 6Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea  \nAvailable online xxx  \nBackground: The tumor immune microenvironment in cancer treatment response and resistance is of increasing interest. This retrospective study characterized and investigated programmed death-ligand 1 (PD-L1), PD-L2, and the immune gene expression signature and their association with clinical outcomes in locoregionally advanced head and neck squamous cell carcinoma (LA HNSCC) .  \nPatients and methods: PD-L1 and PD-L2 expression on tumor and immune-inﬁltrating cells (positivity deﬁned as combined positive score or immunohistochemistry proportion score > 1) and T-cell-inﬂamed gene expression proﬁle (TcellinfGEP) were evaluated in patients with LA HNSCC treated in South Korea from 2000 to 2015 . Correlations among the three biomarkers and their associations with overall survival and recurrence-free survival were assessed. Results: Among 366 patients, 38.8% had human papillomavirus-positive disease. PD-L1-positive, PD-L2-positive, and high TcellinfGEP (􀀃􀀄0 . 162) status were observed in 83 .6%, 85 .4%, and 73 . 2% of patients, respectively; 4 . 1% were posttreatment samples. Correlation between PD-L1 and PD-L2 scores was moderate (rSpearman ¼ 0.50), and each biomarker was slightly less correlated with TcellinfGEP (0 .41-0.45) . PD-L1 expression and high TcellinfGEP status were associated with human papillomavirus positivity. Higher levels of all biomarkers were observed in oral cavity and oropharyngeal cancers compared with other HNSCC sites. In a multivariable analysis that simultaneously adjusted for all three biomarkers, only high TcellinfGEP was signiﬁcantly associated with longer overall survival (adjusted hazard ratio, 0.57; 95% conﬁdence interval 0.33-0.98) and recurrence-free survival (adjusted hazard ratio, 0.41; 95% conﬁdence interval 0 .23-0.74) .  \nConclusion: High TcellinfGEP status, but not PD-L1 or PD-L2 expression, was independently associated with longer survival in patients with LA HNSCC. Results may have implications for evaluating therapies targeting programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) in HNSCC.  \nKey words: head and neck squamous cell carcinoma, PD-L1, PD-L2, gene expression proﬁle, programmed cell death protein 1  \n*Correspondence to: Prof. Byoung Chul Cho, Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seoul, Korea Tel: þ82-2- 2228-8126; Fax: þ82-2-393-3652  \nE-mail: [CBC1971@yuhs.ac](CBC1971@yuhs.ac) (B. C. Cho).  \nProf. Myung-Ju Ahn, Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Seoul, South Korea Tel: þ82-2-3410-3438; Fax: þ82-2- 3410-1754  \nE-mails: silkahn@skku.edu or [silk.ahn@samsung.com](silk.ahn@samsung.com) (M.-J. Ahn).  \nyContributed equally as co-ﬁrst authors.  \n2059-7029/© 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology. This is an open access article under the CC BY-NC-ND license ([http:","cbCail4DNKKW2Rel","https://ap.wps.com/l/cbCail4DNKKW2Rel","pdf",545563,11,"English","# Background\n# Patients and methods\n## Biomarker evaluation\n## Survival and recurrence analyses\n# Results\n# Conclusion\n# Introduction\n## Epidemiology and risk factors\n## PD-1/PD-L1/PD-L2 pathway and clinical context","[{\"question\":\"What biomarkers were evaluated in this study of locoregionally advanced head and neck squamous cell carcinoma?\",\"answer\":\"The study assessed PD-L1 and PD-L2 expression on tumor and immune-infiltrating cells, and the T-cell–inflamed gene expression profile (TcellinfGEP).\"},{\"question\":\"How did the researchers measure PD-L1 and PD-L2 positivity?\",\"answer\":\"Positivity was defined using combined positive score or immunohistochemistry proportion score greater than 1, based on tumor and immune-infiltrating cells.\"},{\"question\":\"Which biomarker was independently associated with survival outcomes?\",\"answer\":\"High TcellinfGEP, but not PD-L1 or PD-L2 expression, was independently associated with longer overall survival and recurrence-free survival in multivariable analysis.\"}]","Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma | PDF",1790045127,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ac689f0db1990dd717157450c5974447.webp",983,1269,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e6e5007efef4470721939bd746158b4.webp",982,1268,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4db2316b61ca3a605dbc2061c6714991.webp",981,1266,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df7e4ebe8ab70e7ca3d765376820c710.webp",980,1265]